| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advanced pleomorphic liposarcomas: clinical outcome and impact of chemotherapy
|
Italiano, A.
|
|
|
23 |
8 |
p. 2205-2206
|
article
|
| 2 |
Annals of Oncology: a statement of editorial intent
|
Vermorken, J.B.
|
|
|
23 |
8 |
p. 1931-1932
|
article
|
| 3 |
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer
|
Doebele, R.C.
|
|
|
23 |
8 |
p. 2094-2102
|
article
|
| 4 |
Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer
|
Andre, F.
|
|
|
23 |
8 |
p. 2059-2064
|
article
|
| 5 |
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study
|
Nuzzo, F.
|
|
|
23 |
8 |
p. 2027-2033
|
article
|
| 6 |
Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy
|
Mathieu, M.C.
|
|
|
23 |
8 |
p. 2046-2052
|
article
|
| 7 |
Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients
|
Tafur, A.J.
|
|
|
23 |
8 |
p. 1998-2005
|
article
|
| 8 |
Clinical biopsychosocial risk factors for depression in lung cancer patients: a comprehensive analysis using data from the Lung Cancer Database Project
|
Shimizu, K.
|
|
|
23 |
8 |
p. 1973-1979
|
article
|
| 9 |
Cruciferous vegetables and cancer risk in a network of case–control studies
|
Bosetti, C.
|
|
|
23 |
8 |
p. 2198-2203
|
article
|
| 10 |
Daily skin care habits and the risk of skin eruptions and symptoms in cancer patients
|
Byun, H.J.
|
|
|
23 |
8 |
p. 1992-1998
|
article
|
| 11 |
Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience
|
Molife, L.R.
|
|
|
23 |
8 |
p. 1968-1973
|
article
|
| 12 |
Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone
|
Wimberger, P.
|
|
|
23 |
8 |
p. 1979-1985
|
article
|
| 13 |
Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib
|
Dranitsaris, G.
|
|
|
23 |
8 |
p. 2103-2108
|
article
|
| 14 |
Durable complete response following chemotherapy and trastuzumab for metastatic HER2-positive breast cancer
|
Gullo, G.
|
|
|
23 |
8 |
p. 2204-2205
|
article
|
| 15 |
Early ultrasonographic finding of septic thrombophlebitis is the main indicator of central venous catheter removal to reduce infection-related mortality in neutropenic patients with bloodstream infection
|
Picardi, M.
|
|
|
23 |
8 |
p. 2122-2128
|
article
|
| 16 |
Editorial board
|
|
|
|
23 |
8 |
p. ii-iii
|
article
|
| 17 |
Effect of autoimmune diseases on mortality and survival in subsequent digestive tract cancers
|
Hemminki, K.
|
|
|
23 |
8 |
p. 2179-2184
|
article
|
| 18 |
Health-related quality of life in recurrent platinum-sensitive ovarian cancer—results from the CALYPSO trial
|
Brundage, M.
|
|
|
23 |
8 |
p. 2020-2027
|
article
|
| 19 |
High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients
|
Grunewald, T.G.P.
|
|
|
23 |
8 |
p. 2185-2190
|
article
|
| 20 |
History of cholelithiasis and cancer risk in a network of case–control studies
|
Tavani, A.
|
|
|
23 |
8 |
p. 2173-2178
|
article
|
| 21 |
How valid are claims for synergy in published clinical studies?
|
Ocana, A.
|
|
|
23 |
8 |
p. 2161-2166
|
article
|
| 22 |
Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer
|
Fountzilas, E.
|
|
|
23 |
8 |
p. 2146-2153
|
article
|
| 23 |
Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling
|
Rodríguez, A.E.
|
|
|
23 |
8 |
p. 2138-2146
|
article
|
| 24 |
Impact of early access to a palliative/supportive care intervention on pain management in patients with cancer
|
Bandieri, E.
|
|
|
23 |
8 |
p. 2016-2020
|
article
|
| 25 |
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma
|
Albiges, L.
|
|
|
23 |
8 |
p. 1943-1953
|
article
|
| 26 |
Lacrimal drainage obstruction in gastric cancer patients receiving S-1 chemotherapy
|
Kim, N.
|
|
|
23 |
8 |
p. 2065-2071
|
article
|
| 27 |
Learning from toxicity patterns in phase I trials during the era of mechanism targeted agents
|
Greystoke, A.
|
|
|
23 |
8 |
p. 1934-1936
|
article
|
| 28 |
Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma
|
Lee, J.-L.
|
|
|
23 |
8 |
p. 2108-2114
|
article
|
| 29 |
Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified?
|
Buggi, F.
|
|
|
23 |
8 |
p. 2042-2046
|
article
|
| 30 |
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study
|
Santini, D.
|
|
|
23 |
8 |
p. 2072-2077
|
article
|
| 31 |
Oxaliplatin-related thrombocytopenia
|
Jardim, D.L.
|
|
|
23 |
8 |
p. 1937-1942
|
article
|
| 32 |
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)
|
Schmitz, S.
|
|
|
23 |
8 |
p. 2153-2161
|
article
|
| 33 |
PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab
|
Jensen, J.D.
|
|
|
23 |
8 |
p. 2034-2042
|
article
|
| 34 |
Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma
|
Chu, H.
|
|
|
23 |
8 |
p. 2114-2121
|
article
|
| 35 |
Preferences for place of death if faced with advanced cancer: a population survey in England, Flanders, Germany, Italy, the Netherlands, Portugal and Spain
|
Gomes, B.
|
|
|
23 |
8 |
p. 2006-2015
|
article
|
| 36 |
Pregnancy unbosoms the heart of breast cancer survivors
|
Altena, R.
|
|
|
23 |
8 |
p. 2206-2208
|
article
|
| 37 |
Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron
|
Aapro, M.
|
|
|
23 |
8 |
p. 1954-1962
|
article
|
| 38 |
Proteins involved in DNA damage response pathways and survival of stage I non-small-cell lung cancer patients
|
Choi, C.M.
|
|
|
23 |
8 |
p. 2088-2093
|
article
|
| 39 |
Racial disparities in Hodgkin's lymphoma: a comprehensive population-based analysis
|
Evens, A.M.
|
|
|
23 |
8 |
p. 2128-2137
|
article
|
| 40 |
Risk factors associated with recurrence after nipple-sparing mastectomy for invasive and intraepithelial neoplasia
|
Petit, J.Y.
|
|
|
23 |
8 |
p. 2053-2058
|
article
|
| 41 |
Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience
|
Wheler, J.J.
|
|
|
23 |
8 |
p. 1963-1967
|
article
|
| 42 |
Screening older cancer patients: first evaluation of the G-8 geriatric screening tool
|
Bellera, C.A.
|
|
|
23 |
8 |
p. 2166-2172
|
article
|
| 43 |
Small cell lung cancer and Chemotherapy advances in small cell lung cancer
|
|
|
|
23 |
8 |
p. 2209
|
article
|
| 44 |
Supportive care and palliative care: a time for unity in diversity
|
Aapro, Matti S.
|
|
|
23 |
8 |
p. 1932-1934
|
article
|
| 45 |
Table of Contents
|
|
|
|
23 |
8 |
p. iv-vi
|
article
|
| 46 |
The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors
|
Sieswerda, E.
|
|
|
23 |
8 |
p. 2191-2198
|
article
|
| 47 |
The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)
|
Aapro, M.
|
|
|
23 |
8 |
p. 1986-1992
|
article
|
| 48 |
To PET or not to PET? That is the question. Staging in anal cancer
|
Bhuva, N.J.
|
|
|
23 |
8 |
p. 2078-2082
|
article
|
| 49 |
Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III study
|
Scagliotti, G.V.
|
|
|
23 |
8 |
p. 2082-2087
|
article
|
Journal description